In today’s real-life patient care we found that NSTEMI, BBB, prior stroke, reduced LVEF, absence of hyperlipidemia, and low CPK level were the strongest predictors for non-invasive therapy in all age groups. The gene discussed is PIK3C2A; the disease is stroke disorder.